Abstract
The human equilibrative nucleoside transporter1 evaluated by SP120 and 10D7G2 had the potential to predict the prognosis in the patients with pancreatic cancer treated with adjuvant gemcitabine: Collaborative study of the JASPAC 01 trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have